| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $255.9M | +23.3% |
| Cost of Revenue | $113.3M | +50.1% |
| Gross Profit | $142.6M | +8.0% |
| R&D Expense | $173.1M | -14.2% |
| SG&A Expense | $95.4M | -4.3% |
| Operating Income | -$166.9M | +20.3% |
| Pre-tax Income | -$102.3M | +44.9% |
| Income Tax | $939K | -33.5% |
| Net Income | -$103.3M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $230.5M | +56.5% |
| Short-term Investments | $164.9M | -19.5% |
| Accounts Receivable | $83.0M | -64.8% |
| Current Assets | $519.3M | -18.2% |
| Total Assets | $726.2M | -11.8% |
| Current Liabilities | $189.1M | -1.4% |
| Total Liabilities | $362.1M | -9.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $13.9M | +108.8% |
| Capital Expenditures | $1.4M | -80.3% |
| Investing Cash Flow | $57.9M | -61.1% |
| Financing Cash Flow | $2.9M | -71.0% |
| Free Cash Flow | $12.5M | +107.6% |
| +44.8% |
| EPS (Basic) | -$1.41 | +45.1% |
| EPS (Diluted) | -$1.41 | +45.1% |
| Stockholders' Equity |
| $364.1M |
| -13.6% |